Actively Recruiting
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Led by Glaukos Corporation · Updated on 2026-02-27
30
Participants Needed
1
Research Sites
28 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
CONDITIONS
Official Title
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Open-angle glaucoma
- 18 years of age or older
You will not qualify if you...
- Subject who is breast-feeding or pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Glaukos Investigative Site
Kenosha, Wisconsin, United States, 53140
Actively Recruiting
Research Team
S
Study Director
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here